• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS FT4 III ASSAY; RADIOIMMUNOASSAY, FREE THYROXINE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS FT4 III ASSAY; RADIOIMMUNOASSAY, FREE THYROXINE Back to Search Results
Model Number FT4 G3
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 06/21/2021
Event Type  malfunction  
Event Description
The initial reporter stated they received questionable results for three samples collected from the same patient and tested with the elecsys ft4 iii assay.The first two samples were each tested on a cobas 8000 e 801 module at another site.The third sample was tested at the customer site on a second e 801 analyzer.The results were reported outside of the laboratory.The patient has been taking levothyroxine for years and has had no symptoms.The first sample resulted in a ft4 value of > 100 pmol/l when tested on the e 801 analyzer at another site.The second sample resulted in a ft4 value of > 100 pmol/l when tested on the e 801 analyzer at another site on (b)(6) 2021.The third sample initially resulted in a ft4 value of 51 pmol/l when tested on the e 801 analyzer at the customer site on (b)(6) 2021.The sample was repeated on a siemens centaur analyzer, resulting in a value of 16.1 pmol/l (expected range = 12 - 23 pmol/l).The serial numbers of the two e 801 analyzers were requested, but not provided.
 
Manufacturer Narrative
A sample from the patient was provided for investigation.The results obtained by the customer could be reproduced.Investigations determined the sample contains an interferent against the streptavidin component of the ft4 assay.Per product labeling: "in rare cases, interference due to extremely high titers of antibodies to analyte-specific antibodies, streptavidin or ruthenium can occur.These effects are minimized by suitable test design." the investigation is ongoing.
 
Manufacturer Narrative
Device code, evaluation method code, evaluation result code, and evaluation conclusion code updated.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS FT4 III ASSAY
Type of Device
RADIOIMMUNOASSAY, FREE THYROXINE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key12306261
MDR Text Key267650470
Report Number1823260-2021-02336
Device Sequence Number1
Product Code CEC
Combination Product (y/n)N
PMA/PMN Number
K131244
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 10/21/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberFT4 G3
Device Catalogue Number07976887190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 07/28/2021
Initial Date FDA Received08/11/2021
Supplement Dates Manufacturer Received07/28/2021
09/30/2021
Supplement Dates FDA Received08/25/2021
10/21/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
DEXAMETHASON (ONCE); LEVOTHYROXINE; TOCILIZUMAB (ONCE)
-
-